Sponsor Pipeline

Precision BioSciences, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Disease Areas
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-15 NCT06680232
Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients…		 Trial sites expanded: 4 -> 7 locations
2026-08-15 NCT06680232
Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients…		 date change Primary completion pushed: 2025-12 -> 2026-12
2026-08-15 NCT06680232
Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients…		 date change Completion pushed: 2026-12 -> 2027-06
Active Trials by Phase
Phase 1/2
1
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07429240 PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular… Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD Recruiting
Phase 1
NCT06680232 Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients… HEPATITIS B CHRONIC Recruiting
Not specified
NCT07254208 A Long-term Observational Study in Participants Who Have Received PBGENE-HBV Chronic HBV Infection Enrolling by Invitation
Disease Areas
Duchenne Muscular Dystrophy (1)
Get alerts when Precision BioSciences, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free